- Home
- ZIP vs PSNL Comparison
ZIP vs PSNL Comparison
Compare ZIP & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZIP
- PSNL
- Stock Information
- Founded
- ZIP 2010
- PSNL 2011
- Country
- ZIP United States
- PSNL United States
- Employees
- ZIP N/A
- PSNL N/A
- Industry
- ZIP Diversified Commercial Services
- PSNL Medical Specialities
- Sector
- ZIP Consumer Discretionary
- PSNL Health Care
- Exchange
- ZIP Nasdaq
- PSNL Nasdaq
- Market Cap
- ZIP 508.3M
- PSNL 460.7M
- IPO Year
- ZIP 2021
- PSNL 2019
- Fundamental
- Price
- ZIP $4.59
- PSNL $5.04
- Analyst Decision
- ZIP Hold
- PSNL Strong Buy
- Analyst Count
- ZIP 5
- PSNL 5
- Target Price
- ZIP $7.80
- PSNL $8.00
- AVG Volume (30 Days)
- ZIP 944.6K
- PSNL 753.6K
- Earning Date
- ZIP 05-08-2025
- PSNL 05-06-2025
- Dividend Yield
- ZIP N/A
- PSNL N/A
- EPS Growth
- ZIP N/A
- PSNL N/A
- EPS
- ZIP N/A
- PSNL N/A
- Revenue
- ZIP $474,001,000.00
- PSNL $85,694,000.00
- Revenue This Year
- ZIP N/A
- PSNL N/A
- Revenue Next Year
- ZIP $12.69
- PSNL $27.82
- P/E Ratio
- ZIP N/A
- PSNL N/A
- Revenue Growth
- ZIP N/A
- PSNL 15.57
- 52 Week Low
- ZIP $4.74
- PSNL $1.14
- 52 Week High
- ZIP $11.25
- PSNL $7.20
- Technical
- Relative Strength Index (RSI)
- ZIP 32.07
- PSNL 69.55
- Support Level
- ZIP $5.11
- PSNL $3.98
- Resistance Level
- ZIP $5.82
- PSNL $5.61
- Average True Range (ATR)
- ZIP 0.31
- PSNL 0.35
- MACD
- ZIP -0.02
- PSNL 0.18
- Stochastic Oscillator
- ZIP 2.68
- PSNL 75.10
About ZIP ZipRecruiter Inc.
ZipRecruiter Inc is an online employment marketplace. It connects millions of job seekers with companies of all sizes. It is a two-sided marketplace for work that simplifies the job market for both job seekers and employers. Unlike traditional online job sites, ZipRecruiter works like a matchmaker curating job opportunities for job seekers, and candidates for employers.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.